# John L. Berk

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/john-l-berk/

## Facts

| Field | Value |
| --- | --- |
| Citations | 18,948 |
| Field | Amyloidosis: Diagnosis, Treatment, Outcomes |
| h-index | 54 |
| i10-index | 119 |
| Last Known Institution | Boston University |
| OpenAlex ID | https://openalex.org/A5015330548 |
| ORCID iD | https://orcid.org/0000-0002-1768-2373 |
| Works | 281 |

## Researcher papers

- [Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis](https://scholariq.org/papers/patisiran-an-rnai-therapeutic-for-hereditary-transthyretin-amyloidosis/)
- [Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy](https://scholariq.org/papers/vutrisiran-in-patients-with-transthyretin-amyloidosis-with-cardiomyopathy/)
- [Patisiran Treatment in Patients with Transthyretin Cardiac Amyloidosis](https://scholariq.org/papers/patisiran-treatment-in-patients-with-transthyretin-cardiac-amyloidosis/)
- [Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation: long-term results in a series of 421 patients](https://scholariq.org/papers/outcome-of-al-amyloidosis-after-high-dose-melphalan-and-autologous-stem-cell/)
- [Eplontersen for Hereditary Transthyretin Amyloidosis With Polyneuropathy](https://scholariq.org/papers/eplontersen-for-hereditary-transthyretin-amyloidosis-with-polyneuropathy/)
- [Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study](https://scholariq.org/papers/long-term-safety-and-efficacy-of-patisiran-for-hereditary-transthyretin-mediated/)

## Researcher topics

- [Amyloidosis: Diagnosis, Treatment, Outcomes](https://scholariq.org/topics/amyloidosis-diagnosis-treatment-outcomes/)
- [Parathyroid Disorders and Treatments](https://scholariq.org/topics/parathyroid-disorders-and-treatments/)
- [Alzheimer's disease research and treatments](https://scholariq.org/topics/alzheimer-s-disease-research-and-treatments/)
- [Dermatological and Skeletal Disorders](https://scholariq.org/topics/dermatological-and-skeletal-disorders/)
- [Neuroendocrine Tumor Research Advances](https://scholariq.org/topics/neuroendocrine-tumor-research-advances/)

## Researcher university

- [Boston University](https://scholariq.org/institutions/boston-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.